Drug for treating cerebral infarction

Abstract

The invention discloses a drug for treating cerebral infarction. The raw materials used for preparing the effective components of the drug are composed of sophora fruit, lethariella cladonioides, medicated leaven, shellac, renanthera coccinea, sweet wormwood, scallion root, blumea balsamifera, Chinese honey locust, serissa serissoide, aconitum kusnezoffii, peucedanum terebinthaceum, herba Inulae, cacumen biotae, magnetite and bile arisaema. The drug disclosed by the invention is prepared by the modern advanced pharmaceutical technology and has the functions of invigorating the circulation of blood, inducing resuscitation, improving blood and oxygen supply of brain tissues, recovering the functions of the cerebral nervous system, and the drug has excellent curative effect on such diseases as cerebral hemorrhage and cerebral infarction and such symptoms caused by cerebral hemorrhage and cerebral infarction sequelae as stroke, partial paralysis, slurred speech, memory deterioration, facial paralysis, and limb stiffness; the drug disclosed by the invention is a pure traditional Chinese medicine preparation, the selected herbs are properly combined, the drug has the functions of replenishing blood for nourishing heart, promoting blood circulation to remove blood stasis, and ensuring resuscitation with aromatics, and is free of toxic side effect, quick in treatment effect on cerebral infarction, high in cure rate and free of sequelae.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating cerebral infarction. Background technique [0002] Cerebral infarction, commonly known as "stroke" or "stroke", is due to cerebral atherosclerosis, vascular intima damage narrows the cerebral artery cavity, and various factors cause local thrombosis, which aggravates or completely occludes the arterial stenosis, resulting in brain tissue damage. Ischemia, hypoxia, necrosis, a cerebrovascular disease that causes neurological dysfunction. Clinically, it mainly manifests as sudden localized neurological deficit symptoms such as hemiplegia, hemiplegia, and slurred speech, which are more common in middle-aged and elderly people aged 45 to 70. [0003] However, with the improvement of living standards, people's pressure is also increasing, the incidence of cerebrovascular diseases is increasing, and the age of onset of cerebral infarction is also ten...

AI Technical Summary

Problems solved by technology

[0003] However, with the improvement of living standards, people's pressure is also increasing, the incidence of cerebrovascular diseases is increasing, and the age of onset of cerebral infarction is also tending to be younger. Blood vessel size is related, and common diseases such as high blood pressure and hyperlipidemia are also risk factors for cerebral infarction; in addition, bad living habits can also easily cause cerebral infarction

[0004] For cerebral infarction diseases, it should be detected in time and treated in time. However, in the existing technology, western medicine treatment of cerebral infarction mainly uses drugs to carry out thrombolysis, anticoagulation, defibrosis, etc. or perform surgical treatment, and the treatment cost is very expensive. Patients bring a heavy economic burden, and the treatment effect is not obvious, and recurrence is very easy

Moreover, most patients with cerebral infarction are the elderly, and surgical treatment is extremely risky for the elderly.